Prevalence of Hepatitis B Infection in the Galilee Region, Israel

June 17, 2014 updated by: Western Galilee Hospital-Nahariya

Primary Aims:

  1. Evaluate HBV (Hepatitis B Virus) infection prevalence among Druze in the Galilee.
  2. Educate the population in order to reduce transmission
  3. Increase awareness among primary care providers

Secondary Aims:

  1. Identify chronic HBV infected patients who need to be followed and treated,
  2. Identify HBV infected women in a childbearing age
  3. Identify non immunized individuals and recommend vaccination
  4. Identify previously vaccinated individuals who are not immunized
  5. Identify previously vaccinated individuals who became infected

Study Design:

Study population is targeted to native Israeli Druze. We aim for evaluating up to 20,000 people from Druze communities in the Galilee area

This work will be divided into three sections:

  1. Increasing awareness: lectures and local events will be taken place in the communities. Written information will be given and primary care-providers mainly family doctors, nurses and obstetric surgeons will be involved.

  2. All participants, upon signing a consent will:

    • Fill up a questioner
    • Checked for weight, height and waist circumflex
    • Have a blood sample taken
  3. Results and recommendations will be forwarded to all participants

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Native Israeli Druze

Description

Inclusion Criteria:

  • All consent adults who are 18 year old or older

Exclusion Criteria:

  • Individuals younger than 18 year old
  • Individuals who cannot or will not sign consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Western Galilee Hospital-Nahariya

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

July 17, 2012

First Submitted That Met QC Criteria

July 17, 2012

First Posted (Estimate)

July 19, 2012

Study Record Updates

Last Update Posted (Estimate)

June 18, 2014

Last Update Submitted That Met QC Criteria

June 17, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0025-12-NHR

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hepatitis B

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe